CDK5R1 and cancer: Additionally, we identified known genes or pathways that control immunogenicity in cancer cells, including PRMT5 (18, 21), ADAR (22), cell cycle (CDK5R1, RPTOR), and the immune suppression related gene TGFBRAP1 (Figure 2F).